Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. by Jarius, S, Paul, F, Franciotta, D, Waters, P, Zipp, F, Hohlfeld, R, Vincent, A, Wildemann, B

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. by Jarius, S, Franciotta, D, Bergamaschi, R, Rauer, S, Wandinger, K, Petereit, H, Maurer, M, Tumani, H, Vincent, A, Eichhorn, P, Wildemann, B, Wick, M, Voltz, R

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. by Jarius, S, Frederikson, J, Waters, P, Paul, F, Akman-Demir, G, Marignier, R, Franciotta, D, Ruprecht, K, Kuenz, B, Rommer, P, Kristoferitsch, W, Wildemann, B, Vincent, A

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing by Jarius, S, Paul, F, Aktas, O, Asgari, N, Dale, RC, De Seze, J, Franciotta, D, Fujihara, K, Jacob, A, Kim, HJ, Kleiter, I, Kümpfel, T, Levy, M, Palace, J, Ruprecht, K, Saiz, A, Trebst, C, Weinshenker, BG, Wildemann, B

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. by Collongues, N, Marignier, R, Jacob, A, Leite, M, Siva, A, Paul, F, Zephir, H, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J

Characterization of NMO and NMOSD Patients with a Late Onset by Collongues, N, Marignier, R, Jacob, A, Siva, A, Paul, F, Zephir, H, Leite, M, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J